RecruitingNCT05475015

3D-MRE for Assessing Cirrhosis, Advanced Chronic Liver Disease and Portal Hypertension

Three-dimensional MR Elastography for Assessing Cirrhosis and Portal Hypertension (CHESS2206): A Prospective Multicenter Study


Sponsor

Shengjing Hospital

Enrollment

150 participants

Start Date

Aug 16, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

How to construct a novel, non-invasive, accurate, and convenient method to achieve prediction of hepatic venous pressure gradient (HVPG) is an important general problem in the management of portal hypertension in cirrhosis or advanced chronic liver disease. We plan to investigate the ability of three demensional-magnetic resonance elastography (3D-MRE) to establish a risk stratification system and perform tailored management for portal hypertension in cirrhosis or advanced chronic liver disease.


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a 3D MRI technique called 3D-MRE (magnetic resonance elastography) that measures liver stiffness non-invasively to see if it can accurately replace an invasive procedure that directly measures blood pressure in the liver (called HVPG), used to assess how advanced liver disease is. **You may be eligible if...** - You are 18 or older and have been diagnosed with advanced chronic liver disease (cirrhosis or severe liver scarring) of any cause - You are already scheduled to have an HVPG measurement (an invasive liver pressure test) as part of your standard care - You can have an MRI performed within one month before your HVPG test **You may NOT be eligible if...** - You have liver cancer or other tumors affecting the area being measured - You have a contraindication to MRI (such as a pacemaker or metal implants) - You have had previous liver or spleen surgery affecting measurement accuracy - You have bile duct blockage or dilation visible on MRI Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICE3D-MRE

All imaging studies were performed by using a 3.0-T MRI system ( GE Healthcare) with a phasedarray body coil.

DEVICEHVPG

HVPG measurements are performed by well-trained interventional radiologists in accordance with standard operating procedures.


Locations(1)

Shengjing Hospital

Shenyang, Liaoning, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05475015


Related Trials